Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar 27;8(5):255-63.
doi: 10.1038/nrneurol.2012.43.

Sex-related factors in multiple sclerosis susceptibility and progression

Affiliations
Review

Sex-related factors in multiple sclerosis susceptibility and progression

Rhonda R Voskuhl et al. Nat Rev Neurol. .

Abstract

The pathogenesis of multiple sclerosis (MS) involves complex interactions between genetic susceptibility and environmental triggers. Clinical observations suggest that the study of sex differences might provide important insight into mechanisms of pathogenesis and progression of the disease in patients. MS occurs more frequently in women than in men, indicating that sex-related factors have an effect on an individual's susceptibility to developing the condition. These factors include hormonal, genetic and environmental influences, as well as gene-environment interactions and epigenetic mechanisms. Interestingly, women do not have a poorer prognosis than men with MS despite a higher incidence of the disease and more-robust immune responses, which suggests a mechanism of resilience. Furthermore, the state of pregnancy has a substantial effect on disease activity, characterized by a reduction in relapse rates during the third trimester but an increased relapse rate in the postpartum period. However, pregnancy has little effect on long-term disability in women with MS. The unravelling of the mechanisms underlying these clinical observations in the laboratory and application of the results to the clinical setting is a unique and potentially fruitful strategy to develop novel therapeutic approaches for MS.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS

The University of Los Angeles, California (UCLA) holds a use patent for estriol treatment of multiple sclerosis for which Dr. Voskuhl is an inventor. Dr. Voskuhl provides consulting advice about MS treatments to Adeona Pharmaceuticals with compensation capped at a maximum of $10,000 per year.

References

    1. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9:520–32. - PubMed
    1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group [see comments] New England Journal of Medicine. 1998;339:285–91. - PubMed
    1. Whitacre CC, Reingold SC, O’Looney PA. A gender gap in autoimmunity. Science. 1999;283:1277–8. - PubMed
    1. Duquette P, et al. The increased susceptibility of women to multiple sclerosis. Canadian Journal of Neurological Sciences. 1992;19:466–71. - PubMed
    1. Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A, McFarland HF, Raine CS. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Annals of Neurology. 1996;39:724–33. - PubMed

Publication types